Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma

Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma

Show other versions (1)

Esophageal squamous cell carcinoma (ESCC) is a common and fatal malignancy with an increasing incidence worldwide. Over the past decade, concurrent chemoradiotherapy (CCRT) with or without surgery is an emerging therapeutic approach for locally advanced ESCC. Unfortunately, many patients exhibit poo...

Full description

Bibliographic Details
Main Authors: Chang, W.-L (Author), Chung, H.-H (Author), Lee, Y.-C (Author), Lin, C.-H (Author), Lin, F.-C (Author), Lin, W.-D (Author), Lu, P.-J (Author), Pan, J.-K (Author), Su, B.-C (Author), Tsai, C.-H (Author), Wang, W.-C (Author), Wang, W.-J (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
acquired concurrent chemoradiotherapy resistance
cell plasticity
epithelial to mesenchymal conversion
esophageal cancer
microRNA
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items